Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Breast cancer (BC), the most common cause of cancer death in women, overtook lung cancer as the leading cause of cancer worldwide in 2020. Although many studies have proposed KIN17 as a biomarker of tumorigenesis in different cancer types, its role in tumor metastasis, particularly in BC metastasis, has been underexplored. This study aimed to explore the role of KIN17 in BC metastasis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Survival analyses was performed to identify the association between KIN17 expression and BC patient survival <i>in silico</i>. Using lentivirus constructs, we developed bidirectional KIN17 expression (KD, knockdown; OE, overexpression) cellular models of luminal-A (Lum-A) breast cancer MCF-7 cells. We performed <i>in vitro</i> wound healing, transwell with and without Matrigel assays, and <i>in vivo</i> tail-vein metastasis assay to evaluate the migration and invasion abilities of MCF-7 with stable KIN17 knockdown or overexpression. Western blotting was performed to compare the changes in protein expression. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>We found that KIN17 expression was associated with poor overall survival (OS), relapse-free survival (RFS), distant metastasis-free survival (DMFS) and post-progression survival (PPS), particularly in Lum-A breast cancer patients. Later, we found that KIN17 knockdown inhibited migration and invasion of MCF-7 cells via regulating EMT-associated signaling pathways in vitro and decreases metastatic spread of the disease <i>in vivo</i>. In contrast, KIN17 overexpression promoted migration and invasion of MCF-7 cells in vitro and increased the metastatic spread of the disease <i>in vivo</i>. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Overall, our findings provide preliminary data which suggests KIN17 of importance to target in metastatic Lum-A patients.</p></section>

Kinin Receptors B1 and B2 Mediate Breast Cancer Cell Migration and Invasion by Activating the FAK-Src Axis

Stimulation of the bradykinin B(1) receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway

Increased Expression of Preprotachykinin-I and Neurokinin Receptors in Human Breast Cancer Cells: Implications for Bone Marrow Metastasis.

Functional and molecular characterization of kinin B1 and B 2 receptors in human bladder cancer: implication of the PI3Kγ pathway

Kinin B2 Receptor Mediates Induction of Cyclooxygenase-2 and is Overexpressed in Head and Neck Squamous Cell Carcinomas

Retinoic acid induces nuclear FAK translocation and reduces breast cancer cell adhesion through Moesin, FAK, and Paxillin

Benzo-[a]-pyrene induces FAK activation and cell migration in MDA-MB-231 breast cancer cells

Involvement of chemokine receptors in breast cancer metastasis

Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer

Bradykinin B1 Receptor Affects Tumor-Associated Macrophage Activity and Glioblastoma Progression

Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis

KIN17 promotes tumor metastasis by activating EMT signaling in luminal ‐A breast cancer

Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer

[Relationship Between LKB1 Gene and Invasion-Related Factors of Breast Cancer Cells].

BCKDK Promotes Ovarian Cancer Proliferation and Migration by Activating the MEK/ERK Signaling Pathway

β2-Adrenoceptor Activation Favor Acquisition of Tumorigenic Properties in Non-Tumorigenic MCF-10A Breast Epithelial Cells

Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression

A Positive Feedback Between Activated Extracellularly Regulated Kinase and Cyclooxygenase/Lipoxygenase Maintains Proliferation and Migration of Breast Cancer Cells

Expression and Effect of Β2 Adrenergic Receptors in Breast Cancer Cells

Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant

Inhibition of Protein Kinase c-Src Reduces the Incidence of Breast Cancer Metastases and Increases Survival in Mice: Implications for Therapy